Email this article 
Risk factors prevalence in patients with chronic critical limb ischemia and comorbidity of ischemic cardiovascular diseases with indications for multivessel revascularization
- Authors: Goloshchapov-Aksenov R.S.1, Rukodaynyy O.V.1, Koledinsky A.G.1, Bagin S.A.1, Volkov P.S.2, Galstyan K.P.3
- Affiliations:
- Peoples' Friendship University of Russia named after Patris Lumumba (RUDN University), Moscow, Russian Federation
- Private Medical Center «Medical On Group-Odintsovo», Moscow Region, Russian Federation
- LLC FMC (Family Medicine Center) Medica, Saint Petersburg, Russian Federation
- Issue: No 3 (2025)
- Pages: 85-91
- Section: Общественное здоровье и организация здравоохранения
- URL: https://bulleten-nriph.ru/journal/article/view/2945
- DOI: https://doi.org/10.69541/NRIPH.2025.03.013
- Cite item
Abstract
Chronic critical limb ischemia (CCLI) is an unfavorable process in patients with obliterating diseases of the arteries of the lower extremities and is accompanied by a high risk of fatal outcomes, limb amputation and disability. Objective. To analyze the prevalence of risk factors in patients with CCLI and comorbidity of ischemic cardiovascular diseases (CVD) with indications for multivessel revascularization, to evaluate their prognostic significance and information content. Materials and methods. A retrospective multicenter research (2018—2024) was performed, big data on medical services in patients (n=782): the group А (n = 657) — patients with CCLI 3—4 st., average age — 74±3.1 years, men 72.8%. The group В (n=125) — patients without CVD and risk factors CVD, average age 44±1.05 years, men — 65.6%. The anamnestic (≥12 months before the development of CCLI) prevalence, information content and prognostic significance of smoking, alcohol consumption, intermittent claudication, hypertension, diabetes, hypercholesterolemia, hyperhomocysteinemia, chronic heart failure, history of myocardial infarction, level of daily physical activity, compliance to medication, self-monitoring of hemodynamic parameters, primary care of cardiologist or cardiovascular surgeon were studied. In patients of group B, the risks of developing CCLI within 12 months in the absence of intermittent claudication were research. The analytical period is 12 months. The following methods: content analysis, statistical, systematization, comparative analysis, mathematical. Results. In patients of group А established a high prevalence and significant prognostic significance and informativeness of Kullback for most of the risk factors of CLLI. In patients of group B, there was no risk of developing CCILI. Conclusion. The results of the research determine the need for personalized multifactorial analysis of the CVD at the primary health care level in all patients over 50 years old for correct the risk factors of CCLI.
About the authors
Roman Sergeevich Goloshchapov-Aksenov
Peoples' Friendship University of Russia named after Patris Lumumba (RUDN University), Moscow, Russian Federation
Email: goloschapovaksenovr@gmail.com
Oleg Vladimirovich Rukodaynyy
Email: rukodaynyy_ov@pfur.ru
Anton Gennad'evich Koledinsky
Email: kard.gkb79@mail.ru
Sergey Andreevich Bagin
Peoples' Friendship University of Russia named after Patris Lumumba (RUDN University), Moscow, Russian Federation
Email: sabg@@gmail.com
Pavel Sergeevich Volkov
Private Medical Center «Medical On Group-Odintsovo», Moscow Region, Russian Federation
Email: xirulk@yandex.ru
Karina Pavlovna Galstyan
LLC FMC (Family Medicine Center) Medica, Saint Petersburg, Russian Federation
Email: skp63@mail.ru
References
- Conte M., Bradbury A., Kolh P. Global vascular guidelines on the management of chronic limb-threatening ischemia. J Vasc Surg. 2019;69(6S):3S—125Se140.
- Aboyans V., Ricco J., Bartelink M. 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS): document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries. Endorsed by: the European Stroke Organization (ESO) the task force for the diagnosis and treatment of peripheral arterial diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J. 2018;39(9):763—816.
- Bailey M., Griffin K., Scott D. Clinical Assessment of Patients with Peripheral Arterial Disease. Seminars in Interventional Radiology. 2014;31(4):292—299.
- Fontaine R., Kim M., Kieny R. Surgical treatment of peripheral circulation disorders. Helv Chir Acta. 1954;(21):499—533.
- Клиническая ангиология: Руководство для врачей в двух томах. А. В. Покровский и др. М.: ОАО «Издательство «Медицина»; 2004.
- Fowkes F., Rudan D., Rudan I. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet. 2013;382(9901):1329—1340.
- Hirsch A., Criqui M., Treat-Jacobson D., Regensteiner J., Creager M., Olin J. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA. 2001;286(11):1317—1324.
- Fowkes F., Rudan D., Rudan I. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet. 2013;(382):1329—1340.
- GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990—2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;(390):1211—1259.
- Gerhard-Herman M., Gornik H., Barrett C. 2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: executive summary: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. J Am Coll Cardiol. 2017;69(11):1465—1508.
- Hinchliffe R., Forsythe R., Apelqvist J. Guidelines on diagnosis, prognosis, and management of peripheral artery disease in patients with foot ulcers and diabetes (IWGDF 2019 update). Diabetes Metab Res Rev. 2020;36(1):e3276.
- Зудин А. М., Засорина М. А., Орлова М. А. Эпидемиологические аспекты хронической критической ишемии нижних конечностей. Хирургия. Журнал им. Н. И. Пирогова. 2014;(10):78—82.
- Апресян А. Ю. Организация хирургического лечения заболеваний артерий нижних конечностей. Современные проблемы здравоохранения и медицинской статистики. 2022;(4):361—377.
- Mustapha J., Katzen B., Neville R. Disease burden and clinical outcomes following initial diagnosis of critical limb ischemia in the Medicare population. JACC Cardiovasc Interv. 2018;(11):1011—1012.
- World Atlas of Prevention and Control of Cardiovascular Diseases. Edited by: Mendis S., Puska P., Norrving B. Geneva: World Health Organization; 2013.
- Айвазян С. А., Бухштабер В. М., Енюков И. С., Мешалкин Л. Д. Прикладная статистика: Классификация и снижение размерности. М.: Финансы и статистика; 1989.
- Criqui M., Langer R., Fronek A., Feigelson H., Klauber M., Mccann T. Mortality Over A Period of 10 Years in Patients with Peripheral Arterial-Disease. N Engl J Med. 1992;(326):381—386.
- Nehler M., Duval S., Diao L., Annex B., Hiatt W., Rogers K., Zakharyan A., Hirsch A. Epidemiology of peripheral arterial disease and critical limb ischemia in an insured national population. J VascSurg. 2014;(60):686—695. doi: 10.1016/j.jvs.2014.03.290
- Jaff M., Cahill K., Yu A., Birnbaum H., Engelhart L. Clinical outcomes and medical care costs among Medicare beneficiaries receiving therapy for peripheral arterial disease. Ann Vasc Surg. 2010;(24):577—587. DOI: 10.1016/j. avsg.2010.03.015
- Абрамов А. Ю., Рукодайный О. В., Кича Д. И., Колединский А. Г., Голощапов-Аксенов Р. С., Зуенкова Ю. А., Морога Д. Ф. Клиническое управление: методические рекомендации. Москва: РУДН; 2022.
- Голощапов-Аксенов Р. С., Рукодайный О. В., Колединский А. Г., Шабуров Р. И., Волков П. С., Тхакур А. С. Модель врача-специалиста на этапе первичной медико-санитарной помощи при сердечно-сосудистых заболеваниях. Комплексные проблемы сердечно-сосудистых заболеваний. 2022;11(4S):125—133. doi: 10.17802/2306-1278-2022-11-4S-125-133
